Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Impact of the EMG normalization method on muscle activation and the antagonist-agonist co-contraction index during active elbow extension: Practical implications for post-stroke subjects.

Chalard A, Belle M, Montané E, Marque P, Amarantini D, Gasq D.

J Electromyogr Kinesiol. 2020 Apr;51:102403. doi: 10.1016/j.jelekin.2020.102403. Epub 2020 Feb 14.

PMID:
32105912
2.

A century of research on spasticity: Editors' opinion.

Pérennou D, Bensmail D, Laffont I, Marque P, Yelnik A.

Ann Phys Rehabil Med. 2019 Nov;62(6):393-396. doi: 10.1016/j.rehab.2019.11.001. Epub 2019 Nov 9. No abstract available.

PMID:
31715275
3.

Venous thrombosis after botulinum therapy in lower limb: A case report and literature review.

Mines ML, Pacheco T, Castel-Lacana E, de Boissezon X, Marque P, Montastruc F.

Ann Phys Rehabil Med. 2019 Nov;62(6):457-458. doi: 10.1016/j.rehab.2019.11.002. Epub 2019 Nov 7. No abstract available.

PMID:
31707008
4.

Post-stroke remodeling processes in animal models and humans.

Cirillo C, Brihmat N, Castel-Lacanal E, Le Friec A, Barbieux-Guillot M, Raposo N, Pariente J, Viguier A, Simonetta-Moreau M, Albucher JF, Olivot JM, Desmoulin F, Marque P, Chollet F, Loubinoux I.

J Cereb Blood Flow Metab. 2020 Jan;40(1):3-22. doi: 10.1177/0271678X19882788. Epub 2019 Oct 23. No abstract available.

PMID:
31645178
5.

Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.

Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C; Botuloscope Group, Pérennou D.

Ann Phys Rehabil Med. 2019 Jul;62(4):207-213. doi: 10.1016/j.rehab.2019.06.003. Epub 2019 Jun 20.

6.

Contribution of FEF to Attentional Periodicity during Visual Search: A TMS Study.

Dugué L, Beck AA, Marque P, VanRullen R.

eNeuro. 2019 Jun 24;6(3). pii: ENEURO.0357-18.2019. doi: 10.1523/ENEURO.0357-18.2019. Print 2019 May/Jun.

7.

Supraspinal Control of Recurrent Inhibition during Anisometric Contractions.

Barrué-Belou S, Marque P, Duclay J.

Med Sci Sports Exerc. 2019 Nov;51(11):2357-2365. doi: 10.1249/MSS.0000000000002042.

PMID:
31107836
8.

Spastic co-contraction, rather that spasticity, is associated with impaired active function in adults with acquired brain injury: A pilot study.

Chalard A, Amarantini D, Tisseyre J, Marque P, Tallet J, Gasq D.

J Rehabil Med. 2019 Apr 1;51(4):307-311. doi: 10.2340/16501977-2528.

9.

Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.

Chollet F, Rigal J, Marque P, Barbieux-Guillot M, Raposo N, Fabry V, Albucher JF, Pariente J, Loubinoux I.

Curr Neurol Neurosci Rep. 2018 Oct 23;18(12):100. doi: 10.1007/s11910-018-0904-9. Review.

PMID:
30353288
10.

Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, investigator blinded study.

Bonnyaud C, Gallien P, Decavel P, Marque P, Aymard C, Pellas F, Isner ME, Boyer FC, Muller F, Daviet JC, Dehail P, Perrouin-Verbe B, Bayle N, Coudeyre E, Perennou D, Laffont I, Ropers J, Domingo-Saidji NY, Bensmail D, Roche N; ADJU-TOX Study Group.

BMJ Open. 2018 Aug 30;8(8):e020915. doi: 10.1136/bmjopen-2017-020915.

11.

Mirror Movements are Linked to Executive Control in Healthy and Brain-injured Adults.

Tisseyre J, Amarantini D, Chalard A, Marque P, Gasq D, Tallet J.

Neuroscience. 2018 May 21;379:246-256. doi: 10.1016/j.neuroscience.2018.03.027. Epub 2018 Mar 26.

PMID:
29592842
12.

Recurrent inhibition is higher in eccentric compared to isometric and concentric maximal voluntary contractions.

Barrué-Belou S, Marque P, Duclay J.

Acta Physiol (Oxf). 2018 Aug;223(4):e13064. doi: 10.1111/apha.13064. Epub 2018 Mar 30.

PMID:
29575639
13.

Five-day course of paired associative stimulation fails to improve motor function in stroke patients.

Tarri M, Brihmat N, Gasq D, Lepage B, Loubinoux I, De Boissezon X, Marque P, Castel-Lacanal E.

Ann Phys Rehabil Med. 2018 Mar;61(2):78-84. doi: 10.1016/j.rehab.2017.11.002. Epub 2017 Dec 20.

14.

Action, observation or imitation of virtual hand movement affect differently regions of the mirror neuron system and the default mode network.

Brihmat N, Tarri M, Quidé Y, Anglio K, Pavard B, Castel-Lacanal E, Gasq D, De Boissezon X, Marque P, Loubinoux I.

Brain Imaging Behav. 2018 Oct;12(5):1363-1378. doi: 10.1007/s11682-017-9804-x.

PMID:
29243119
15.

Cerebral imaging of post-stroke plasticity and tissue repair.

Loubinoux I, Brihmat N, Castel-Lacanal E, Marque P.

Rev Neurol (Paris). 2017 Nov;173(9):577-583. doi: 10.1016/j.neurol.2017.09.007. Epub 2017 Oct 3. Review.

PMID:
28985963
16.

Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.

O'Dell MW, Brashear A, Jech R, Lejeune T, Marque P, Bensmail D, Ayyoub Z, Simpson DM, Volteau M, Vilain C, Picaut P, Gracies JM.

PM R. 2018 Jan;10(1):1-10. doi: 10.1016/j.pmrj.2017.06.008. Epub 2017 Jun 19.

PMID:
28634000
17.

Predictive position computations mediated by parietal areas: TMS evidence.

Edwards G, Paeye C, Marque P, VanRullen R, Cavanagh P.

Neuroimage. 2017 Jun;153:49-57. doi: 10.1016/j.neuroimage.2017.03.043. Epub 2017 Mar 22.

PMID:
28341161
18.

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.

Montastruc J, Marque P, Moulis F, Bourg V, Lambert V, Durrieu G, Montastruc JL, Montastruc F.

Dev Med Child Neurol. 2017 Mar;59(3):329-334. doi: 10.1111/dmcn.13286. Epub 2016 Sep 28.

19.

Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study.

Peyronnet B, Castel-Lacanal E, Roumiguie M, Even L, Marque P, Soulié M, Rischmann P, Game X.

Neurourol Urodyn. 2017 Mar;36(3):734-739. doi: 10.1002/nau.23009. Epub 2016 Mar 31.

PMID:
27037973
20.

Neural adaptations to submaximal isokinetic eccentric strength training.

Barrué-Belou S, Amarantini D, Marque P, Duclay J.

Eur J Appl Physiol. 2016 May;116(5):1021-30. doi: 10.1007/s00421-016-3367-1. Epub 2016 Mar 30.

PMID:
27030127
21.

Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.

Castel-Lacanal E, Gamé X, Clanet M, De Boissezon X, Brassat D, Rischmann P, Marque P.

Neurourol Urodyn. 2017 Mar;36(3):706-709. doi: 10.1002/nau.23002. Epub 2016 Mar 29.

PMID:
27028504
22.

Résultats de la stimulation du nerf tibial de type TENS dans le traitement des douleurs pelviennes chroniques.

Roulette P, Castel-Lacanal E, Guillotreau J, Soler J, Marque P, Soulié M, Rischmann P, Gamé X.

Prog Urol. 2015 Nov;25(13):848. doi: 10.1016/j.purol.2015.08.265. French. No abstract available.

PMID:
26544459
23.

Résultats des injections intra-détrusoriennes de toxine botulique A chez les patients spina-bifida.

Peyronnet B, Hascoet J, Roumiguié M, Damphousse M, Castel-Lacanal E, Marque P, Soulié M, Brochard C, Siproudhis L, Rischmann P, Manunta A, Gamé X.

Prog Urol. 2015 Nov;25(13):737-8. doi: 10.1016/j.purol.2015.08.044. French. No abstract available.

PMID:
26544239
24.

Comparaison du changement de toxine et de la réinjection de la même toxine chez les patients en échec d'injections de toxine botulique pour hyperactivité détrusorienne neurogène.

Peyronnet B, Castel-Lacanal E, Manunta A, Roumiguié M, Marque P, Rischmann P, Gamé X.

Prog Urol. 2015 Nov;25(13):736-7. doi: 10.1016/j.purol.2015.08.042. French. No abstract available.

PMID:
26544236
25.

Injections intra-détrusoriennes d'onabotulinum toxine A (Botox(®)) ou d'abobotulinum toxine A (Dysport(®)) dans le traitement de l'hyperactivité détrusorienne neurogène : une étude controlée non randomisée.

Peyronnet B, Castel-Lacanal E, Roumiguie M, Marque P, Rischmann P, Gamé X.

Prog Urol. 2015 Nov;25(13):736. doi: 10.1016/j.purol.2015.08.041. French. No abstract available.

PMID:
26544235
26.

Résultats de la stimulation du nerf tibial de type TENS dans le traitement de l'hyperactivité vésicale réfractaire idiopathique.

Roulette P, Castel-Lacanal E, Guillotreau J, Lacan H, Soler J, Malavaud B, Marque P, Soulié M, Rischmann P, Gamé X.

Prog Urol. 2014 Nov;24(13):844-5. doi: 10.1016/j.purol.2014.08.136. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461662
27.

Suivi sur 15ans des patients implantés d'un boîtier de neuromodulation des racines sacrées pour troubles vésico-sphinctériens.

Roulette P, Castel-Lacanal E, Guillotreau J, Rouvellat P, Malavaud B, Marque P, Soulié M, Rischmann P, Gamé X.

Prog Urol. 2014 Nov;24(13):844. doi: 10.1016/j.purol.2014.08.135. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461661
28.

Résultats de la neuromodulation des racines sacrées postérieures dans le traitement des troubles de la phase mictionnelle sans obstruction sous-vésicale.

Tostivint V, Roulette P, Castel-Lacanal E, Guillotreau J, Malavaud B, Marque P, Soulie M, Rischmann P, Game X.

Prog Urol. 2014 Nov;24(13):843-4. doi: 10.1016/j.purol.2014.08.134. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461660
29.

Reprise chirurgicale des patients traités par neuromodulation des racines sacrées pour troubles vésico-sphinctériens : suivi sur 15ans.

Roulette P, Castel-Lacanal E, Guillotreau J, Rouvellat P, Malavaud B, Marqué P, Soulié M, Rischmann P, Gamé X.

Prog Urol. 2014 Nov;24(13):828. doi: 10.1016/j.purol.2014.08.102. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461629
30.

Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.

Peyronnet B, Castel-Lacanal E, Manunta A, Roumiguié M, Marque P, Rischmann P, Gamé X.

Int J Urol. 2015 Dec;22(12):1160-5. doi: 10.1111/iju.12950. Epub 2015 Sep 22.

31.

Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity.

Peyronnet B, Roumiguié M, Castel-Lacanal E, Guillotreau J, Marque P, Rischmann P, Gamé X.

World J Urol. 2016 May;34(5):755-61. doi: 10.1007/s00345-015-1666-5. Epub 2015 Aug 18.

PMID:
26282099
32.

Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.

Peyronnet B, Roumiguié M, Castel-Lacanal E, Guillotreau J, Malavaud B, Marque P, Rischmann P, Gamé X.

Neurourol Urodyn. 2016 Feb;35(2):267-70. doi: 10.1002/nau.22712. Epub 2014 Dec 18.

PMID:
25524826
33.

[Study of the sensitivity of renal ultrasonography as an indirect means of assessing renal function in patients with neurogenic bladder, from a cohort of 103 patients].

Braley-Berthoumieux E, Gamé X, Marque P, de Boissezon X, Rischmann P, Castel-Lacanal E.

Prog Urol. 2014 Dec;24(17):1114-9. doi: 10.1016/j.purol.2014.09.044. Epub 2014 Oct 23. French.

PMID:
25450757
34.

Theta oscillations modulate attentional search performance periodically.

Dugué L, Marque P, VanRullen R.

J Cogn Neurosci. 2015 May;27(5):945-58. doi: 10.1162/jocn_a_00755. Epub 2014 Nov 12.

PMID:
25390199
35.

An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapists.

Ory Magne F, Fabre N, Gu C, Pastorelli C, Tardez S, Marchat JC, Marque P, Brefel Courbon C.

Rev Neurol (Paris). 2014 Nov;170(11):680-4. doi: 10.1016/j.neurol.2014.05.009. Epub 2014 Oct 3.

PMID:
25287732
36.

For a long time we thought all was lost….

Marque P.

Ann Phys Rehabil Med. 2014 Nov;57(8):487-488. doi: 10.1016/j.rehab.2014.09.006. Epub 2014 Sep 24. No abstract available.

37.

Post-stroke hemiplegia rehabilitation: evolution of the concepts.

Marque P, Gasq D, Castel-Lacanal E, De Boissezon X, Loubinoux I.

Ann Phys Rehabil Med. 2014 Nov;57(8):520-529. doi: 10.1016/j.rehab.2014.08.004. Epub 2014 Aug 23. Review.

38.

Between-day reliability of centre of pressure measures for balance assessment in hemiplegic stroke patients.

Gasq D, Labrunée M, Amarantini D, Dupui P, Montoya R, Marque P.

J Neuroeng Rehabil. 2014 Mar 21;11:39. doi: 10.1186/1743-0003-11-39.

39.

Transcranial magnetic stimulation in brain injury.

Castel-Lacanal E, Tarri M, Loubinoux I, Gasq D, de Boissezon X, Marque P, Simonetta-Moreau M.

Ann Fr Anesth Reanim. 2014 Feb;33(2):83-7. doi: 10.1016/j.annfar.2013.11.006. Epub 2013 Dec 27. Review.

PMID:
24378049
40.

Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study).

Labrunée M, Despas F, Marque P, Guiraud T, Galinier M, Senard JM, Pathak A.

PLoS One. 2013 Nov 12;8(11):e79438. doi: 10.1371/journal.pone.0079438. eCollection 2013.

41.

Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.

Castel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, Bourg V, Viala F, Rischmann P, Marque P.

Neurourol Urodyn. 2015 Jan;34(1):32-6. doi: 10.1002/nau.22495. Epub 2013 Sep 23.

PMID:
24115110
42.

Posterior tibial tendon transfer in the spastic brain-damaged adult does not lead to valgus flatfoot.

Gasq D, Molinier F, Reina N, Dupui P, Chiron P, Marque P.

Foot Ankle Surg. 2013 Sep;19(3):182-7. doi: 10.1016/j.fas.2013.04.001. Epub 2013 May 10.

PMID:
23830167
43.

Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.

Castel-Lacanal E, Gamé X, De Boissezon X, Guillotreau J, Braley-Berthoumieux E, Terracol C, Gasq D, Labrunee M, Viala F, Rischmann P, Clanet M, Marque P.

World J Urol. 2013 Dec;31(6):1445-50. doi: 10.1007/s00345-012-1017-8. Epub 2013 Jan 6.

PMID:
23292297
44.

Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis.

Guillotreau J, Panicker JN, Castel-Lacanal E, Viala F, Roumiguié M, Malavaud B, Marque P, Clanet M, Rischmann P, Gamé X.

Urology. 2012 Oct;80(4):852-7. doi: 10.1016/j.urology.2012.06.039. Epub 2012 Aug 29.

PMID:
22939550
45.

[Pathophysiology of spasticity].

Marque P, Brassat D.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S36-44. doi: 10.1016/S0035-3787(12)70045-0. Review. French.

PMID:
22721363
46.

[External sphincterotomy using bipolar vaporisation in saline. First results].

Even L, Guillotreau J, Mingat N, Castel-Lacanal E, Braley E, Malavaud B, Marque P, Rischmann P, Gamé X.

Prog Urol. 2012 Jul;22(8):462-6. doi: 10.1016/j.purol.2012.04.009. Epub 2012 May 31. French.

PMID:
22732581
47.

Construction and pilot assessment of the Upper Limb Assessment in Daily Living Scale.

Rousseaux M, Bonnin-Koang HY, Darné B, Marque P, Parratte B, Schnitzler A, Dehail P, Bradai N, Viton JM, Daveluy W, Yelnik A, Zadikian M, Benaïm C.

J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):594-600. doi: 10.1136/jnnp-2011-300929. Epub 2012 Mar 6.

PMID:
22396440
48.

The phase of ongoing oscillations mediates the causal relation between brain excitation and visual perception.

Dugué L, Marque P, VanRullen R.

J Neurosci. 2011 Aug 17;31(33):11889-93. doi: 10.1523/JNEUROSCI.1161-11.2011.

49.

A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.

Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P.

Eur J Paediatr Neurol. 2011 Sep;15(5):439-48. doi: 10.1016/j.ejpn.2010.04.006. Epub 2011 Jul 13.

PMID:
21745754
50.

Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction.

Guillotreau J, Castel-Lacanal E, Roumiguié M, Bordier B, Doumerc N, De Boissezon X, Malavaud B, Marque P, Rischmann P, Gamé X.

Neurourol Urodyn. 2011 Nov;30(8):1503-6. doi: 10.1002/nau.21121. Epub 2011 Jun 14.

PMID:
21674595

Supplemental Content

Loading ...
Support Center